Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 1998, p. 3051-3054, Vol. 36, No. 10
Diagnostic Laboratory of Infectious Diseases
and Perinatal Screening, National Institute of Public Health and the
Environment, 3720 BA Bilthoven, The
Netherlands1;
Department of
Mycobacteriology, Division of Diagnostics, Statens Serum Institut, 2300 Copenhagen S, Denmark2;
Pan American
Institute for Food Protection and Zoonoses, Martinez 1640, Argentina3;
Departamento de
Microbiologia, Imunologia e Parasitologia, Universidade Federal de
São Paulo, 862.3, Andar, São Paulo,
Brazil4;
Veterinary Research Institute,
Hudcova 70, 621 32 Brno, Czech Republic5;
Laboratoire de Référence des Mycobactéries,
Institut Pasteur, 75724 Paris Cedex 15, France6;
Unité de la Tuberculose et des Mycobactéries,
Institut Pasteur, 97165 Pointe-à-Pitre Cedex, Guadeloupe, French
West Indies7;
Clinic of Infectious
Diseases,
Received 13 April 1998/Returned for modification 6 June
1998/Accepted 4 July 1998
Mycobacterium avium has become a major human pathogen,
primarily due to the emergence of the AIDS epidemic. Restriction
fragment length polymorphism (RFLP) typing, using insertion sequence
IS1245 as a probe, provides a powerful tool in the
molecular epidemiology of M. avium-related infections and
will facilitate well-founded studies into the sources of M. avium infections in animal and environmental reservoirs. The
standardization of this technique allows computerization of
IS1245 RFLP patterns for comparison on a local level and
the establishment of M. avium DNA fingerprint databases for
interlaboratory comparison. Moreover, by combining international DNA
typing results of M. avium complex isolates from a broad
spectrum of sources, long-lasting questions on the epidemiology of this
major agent of mycobacterial infections will be answered.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
IS1245 Restriction Fragment Length
Polymorphism Typing of Mycobacterium avium Isolates:
Proposal for Standardization
*
Corresponding author. Mailing address: Mycobacteria
Department, National Institute of Public Health and the Environment
(RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands. Phone: 31 30 2742363. Fax: 31 30 2744418. E-mail:
D.van.Soolingen{at}rivm.nl.
Journal of Clinical Microbiology, October 1998, p. 3051-3054, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|